177477-27-9

Basic information

• Product Name: 4-[3-(N-Glycyl-N-methylamino)-2,6-dichlorobenzyloxy]-2-methoxy-1-methyl-1H-benzimidazole
• Synonyms: 4-[3-(N-Glycyl-N-methylamino)-2,6-dichlorobenzyloxy]-2-methoxy-1-methyl-1H-benzimidazole
• CAS NO: 177477-27-9
• Molecular Weight: 423.299
• Mol File: 177477-27-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4-[3-(N-Glycyl-N-methylamino)-2,6-dichlorobenzyloxy]-2-methoxy-1-methyl-1H-benzimidazole(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[3-(N-Glycyl-N-methylamino)-2,6-dichlorobenzyloxy]-2-methoxy-1-methyl-1H-benzimidazole(177477-27-9)
• EPA Substance Registry System: 4-[3-(N-Glycyl-N-methylamino)-2,6-dichlorobenzyloxy]-2-methoxy-1-methyl-1H-benzimidazole(177477-27-9)

Safety Data

• Hazardous Substances Data: 177477-27-9(Hazardous Substances Data)

Upstream product

• 177477-26-8 4-[2,6-Dichloro-3-[N-(phthalimidoacetyl)-N-methylamino]-benzyloxy]-2-methoxy-1-methyl-1H-benzimidazole 
• 602-00-6 3-hydroxy-2-nitrobenzoic acid 
• 24115-89-7 3-benzyloxy-2-nitrobenzoic acid 
• 94863-06-6 benzyl 3-benzyloxy-2-nitrobenzoate 
• 160647-01-8 2,6-Dichloro-3-nitrobenzyl alcohol 
• 177477-89-3 4-hydroxy-2-methoxy-1-methyl-1H-benzimidazole 
• 177477-87-1 2-amino-3-benzyloxy-N-methylaniline 
• 177477-68-8 3-benzyloxy-N-methyl-2-nitroaniline 
• 177477-88-2 4-benzyloxy-2-methoxy-1-methyl-1H-benzimidazole 
• 177477-63-3 tert-butyl 3-(benzyloxy)-2-nitrophenylcarbamate 
• 167837-45-8 3-amino-1-(tert-butyldiphenylsilyloxymethyl)-2,6-dichlorobenzene 
• 177477-65-5 tert-Butyl N-(3-benzyloxy-2-nitrophenyl)-N-methylcarbamate 
• 167837-48-1 N-(2,4-dichloro-3-(hydroxymethyl)phenyl)-2-(1,3-dioxoisoindolin-2-yl)-N-methylacetamide 
• 167837-44-7 tert-butyl(2,6-dichloro-3-nitrobenzyloxy)diphenylsilane 

Relevant articles and documents

Benzimidazole compounds as bradykinin antagonists

PCT No. PCT/JP95/01478 Sec. 371 Date Feb. 3, 1997 Sec. 102(e) Date Feb. 3, 1997 PCT Filed Jul. 25, 1995 PCT Pub. No. WO96/04251 PCT Pub. Date Feb. 15, 1996This invention relates to a heterocyclic compound of the formula: wherein a group of the formula: is a group of the formula: etc., X is O, S or N-R5, R1 is lower alkyl, etc., R5 is hydrogen, lower alkyl, etc., R2 is hydrogen, halogen, lower alkyl, etc., R3 is halogen, lower alkyl, etc., R4 is amino optionally having suitable substituent(s), and A is lower alkylene, and a salt thereof, to processes for preparation thereof, and to a pharmaceutical composition comprising the same for the prevention and/or the treatment of bradykinin or its analogues mediated diseases in human being or animals.